Diego Vergani

Active 1979–2024

116
Papers
19,643
Citations
86
h-index
116
i10-index

Citations

Citations per year for Diego Vergani1980: 1 citations1983: 7 citations1984: 10 citations1985: 11 citations1986: 11 citations1987: 17 citations1988: 7 citations1989: 6 citations1990: 18 citations1991: 16 citations1992: 15 citations1993: 22 citations1994: 22 citations1995: 19 citations1996: 17 citations1997: 18 citations1998: 21 citations1999: 32 citations2000: 39 citations2001: 50 citations2002: 67 citations2003: 52 citations2004: 61 citations2005: 44 citations2006: 77 citations2007: 112 citations2008: 133 citations2009: 145 citations2010: 163 citations2011: 186 citations2012: 214 citations2013: 216 citations2014: 149 citations2015: 196 citations2016: 120 citations2017: 172 citations2018: 142 citations2019: 429 citations2020: 383 citations2021: 453 citations2022: 365 citations2023: 281 citations2024: 443 citations2025: 189 citations2026: 1 citations1981–1982: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 988 citing papers, 20.7% of this breakdownChina: 556 citing papers, 11.7% of this breakdownUnited Kingdom: 521 citing papers, 10.9% of this breakdownItaly: 333 citing papers, 7% of this breakdownGermany: 326 citing papers, 6.8% of this breakdownCanada: 200 citing papers, 4.2% of this breakdownFrance: 149 citing papers, 3.1% of this breakdownJapan: 146 citing papers, 3.1% of this breakdownNetherlands: 131 citing papers, 2.8% of this breakdownSpain: 113 citing papers, 2.4% of this breakdownSwitzerland: 94 citing papers, 2% of this breakdownAustralia: 76 citing papers, 1.6% of this breakdown
0%20.7%Other 23.7%

Fields

  • Medicine70.8%
  • Immunology and Microbiology13.6%
  • Biochemistry, Genetics and Molecular Biology7.8%
  • Pharmacology, Toxicology and Pharmaceutics5.6%
  • Neuroscience0.8%
  • Nursing0.3%
  • Other1.1%

Topics

  • Liver Diseases and Immunity11.1%
  • Liver Disease Diagnosis and Treatment10.4%
  • Hepatitis B Virus Studies6.8%
  • Hepatitis C virus research6%
  • Immune Cell Function and Interaction3.8%
  • Liver Disease and Transplantation3.8%
  • Other58.1%

Coauthors

All papers

Open in search
  1. Autoimmune hepatitis

    Authors: , , , , , , , - Nature Reviews Disease Primers 2018 cited by 425

  2. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anna Licata, M. Isabel Lucena, Giorgina Mieli‐Vergani, Diego Vergani, Einar S. Björnsson - Journal of Hepatology 2023 cited by 150

  3. Autoimmmune hepatitis

    Authors: , , - Cellular and Molecular Immunology 2021 cited by 183

  4. The importance of immune dysfunction in determining outcome in acute liver failure

    Authors: , , , - Journal of Hepatology 2008 cited by 364

  5. Diagnosis and Management of Autoimmune Hepatitis

    Authors: , , , , , , - Hepatology 2010 cited by 1,427

  6. Diagnosis and Management of Pediatric Autoimmune Liver Disease

    Authors: , , , , , , , , , , , , , - Journal of Pediatric Gastroenterology and Nutrition 2017 cited by 344

  7. Regulatory T cells in autoimmune hepatitis: an updated overview

    Authors: , , - Journal of Autoimmunity 2021 cited by 86

  8. Autoimmune hepatitis – Update 2015

    Authors: , , - Journal of Hepatology 2015 cited by 374

  9. PDIA3 epitope-driven immune autoreactivity contributes to hepatic damage in type 2 diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Science Immunology 2022 cited by 48

  10. The Role of Virus-Specific Cd8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection

    Authors: , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2000 cited by 802

  11. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments

    Authors: , , - World Journal of Gastroenterology 2017 cited by 140

  12. Dysfunctional CD39POS regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis

    Authors: , , , , , , , , - Hepatology 2013 cited by 187

  13. Aberrant hepatic trafficking of gut‐derived T cells is not specific to primary sclerosing cholangitis

    Authors: , , , , , , , , , , , , , , , , , , - Hepatology 2021 cited by 46

  14. Regulatory T-cells in autoimmune diseases: Challenges, controversies and—yet—unanswered questions

    Authors: , , , , - Autoimmunity Reviews 2014 cited by 287

  15. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway

    Authors: , , , , , , - Hepatology 2012 cited by 146

  16. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group

    Authors: , , , , , , , - Journal of Hepatology 2004 cited by 452

  17. Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease

    Authors: , , , , , - Journal of Hepatology 2004 cited by 405

  18. Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans

    Authors: , , , , , , , , , , , , , , , , , , - Hepatology 2012 cited by 290

  19. A Multifaceted Imbalance of T Cells with Regulatory Function Characterizes Type 1 Autoimmune Hepatitis†,‡

    Authors: , , , , , , , , , , , , - Hepatology 2010 cited by 200

  20. A novel “humanized mouse” model for autoimmune hepatitis and the association of gut microbiota with liver inflammation

    Authors: , , , , , , , , , , , , , , - Hepatology 2015 cited by 122

  21. Direct ex vivo analysis of hepatitis B virus-specific CD8+ T cells associated with the control of infection

    Authors: , , , , , , , , , , , , - Gastroenterology 1999 cited by 365

  22. In autoimmune hepatitis type 1 or the autoimmune hepatitis–sclerosing cholangitis variant defective regulatory T‐cell responsiveness to IL‐2 results in low IL‐10 production and impaired suppression

    Authors: , , , , , , , , , - Hepatology 2015 cited by 103

  23. Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice

    Authors: , , - Clinical Reviews in Allergy & Immunology 2021 cited by 62

  24. Histological and serological features of acute liver injury after SARS-CoV-2 vaccination

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andreas Cerny, Heiner Wedemeyer, Diego Vergani, Giorgina Mieli‐Vergani, M. Isabel Lucena, Raúl J. Andrade, Yoh Zen, Richard Taubert, Benedetta Terziroli Beretta‐Piccoli - JHEP Reports 2022 cited by 52